Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.

Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M.

Can J Cardiol. 2013 Nov;29(11):1408-14. doi: 10.1016/j.cjca.2013.04.009. Epub 2013 Jun 28.

PMID:
23816280
2.

Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.

Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS.

Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):632-41. doi: 10.1161/CIRCOUTCOMES.109.906214. Epub 2010 Oct 5.

3.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
4.

Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.

Naderi SH, Bestwick JP, Wald DS.

Am J Med. 2012 Sep;125(9):882-7.e1. doi: 10.1016/j.amjmed.2011.12.013. Epub 2012 Jun 27.

PMID:
22748400
5.
6.

Long-term adherence with cardiovascular drug regimens.

Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED.

Am Heart J. 2006 Jan;151(1):185-91.

PMID:
16368315
7.

Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.

Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):228-35. doi: 10.1161/CIRCOUTCOMES.108.813600. Epub 2009 Apr 28.

8.

Kidney function and long-term medication adherence after myocardial infarction in the elderly.

Chang TI, Desai M, Solomon DH, Winkelmayer WC.

Clin J Am Soc Nephrol. 2011 Apr;6(4):864-9. doi: 10.2215/CJN.07290810. Epub 2011 Jan 13.

9.

Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.

Patel BV, Remigio-Baker RA, Thiebaud P, Preblick R, Plauschinat C.

BMC Fam Pract. 2008 Nov 6;9:61. doi: 10.1186/1471-2296-9-61.

10.

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.

Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.

Clin Ther. 2008 Nov;30(11):2167-79. doi: 10.1016/j.clinthera.2008.11.012.

PMID:
19108805
12.

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS.

Am Heart J. 2008 Apr;155(4):772-9. doi: 10.1016/j.ahj.2007.12.011.

PMID:
18371492
13.

Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.

Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS.

J Am Coll Cardiol. 2013 Jan 22;61(3):295-301. doi: 10.1016/j.jacc.2012.10.018. Epub 2012 Dec 12.

14.

Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.

Austin PC, Tu JV, Ko DT, Alter DA.

CMAJ. 2008 Oct 21;179(9):901-8. doi: 10.1503/cmaj.080295.

15.

Associations of kidney function with cardiovascular medication use after myocardial infarction.

Winkelmayer WC, Levin R, Setoguchi S.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1415-22. doi: 10.2215/CJN.02010408. Epub 2008 Jul 9.

16.

[Medication adherence to secondary prevention for coronary artery disease].

Rossi E, Perman G, Michelangelo H, Alonzo CB, Brescacin L, Kopitowski KS, Navarro Estrada JL.

Medicina (B Aires). 2014;74(2):99-103. Spanish.

17.

Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.

Mathews R, Wang TY, Honeycutt E, Henry TD, Zettler M, Chang M, Fonarow GC, Peterson ED; TRANSLATE-ACS Study Investigators.

Am Heart J. 2015 Jul;170(1):62-9. doi: 10.1016/j.ahj.2015.03.019. Epub 2015 Apr 2.

18.

Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.

Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.

Pharmacotherapy. 2014 May;34(5):464-72.

PMID:
24877186
19.

Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.

Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD, Bosworth HB, Radcliff T, Davis R, Mun H, Weaver J, Barnett C, Barón A, Del Giacco EJ.

JAMA Intern Med. 2014 Feb 1;174(2):186-93. doi: 10.1001/jamainternmed.2013.12944.

PMID:
24247275
20.

Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome.

Leung KC, Pannu N, Tan Z, Ghali WA, Knudtson ML, Hemmelgarn BR, Tonelli M, James MT; APPROACH and AKDN Investigators.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1840-8. doi: 10.2215/CJN.03460414. Epub 2014 Oct 15.

Supplemental Content

Support Center